Presenting History

When evaluating a neonate with jaundice or hyperbilirubinemia, obtain an exhaustive chronological account of onset, progression, distribution, associated feeding and neurological symptoms, and stool/urine characteristics to differentiate unconjugated from conjugated hyperbilirubinemia and identify hemolytic, infectious, metabolic, or cholestatic etiologies.

• Onset, Progression, and Distribution of Jaundice: Document exact age at onset in hours of life. Onset < 24 hours: pathological jaundice until proven otherwise (hemolytic disease — Rh, ABO, G6PD, minor group; intrauterine TORCH; congenital spherocytosis). Onset 24–72 hours: physiological jaundice, exaggerated physiological, cephalhematoma/extravasated blood, polycythemia, breastfed jaundice (lactation failure). Onset > 72 hours to 2 weeks: sepsis, cephalhematoma, breast milk jaundice, hypothyroidism, Crigler-Najjar, extravascular blood resolution. Prolonged jaundice (> 14 days in term, > 21 days in preterm): unconjugated (breast milk jaundice, hypothyroidism, Crigler-Najjar, pyloric stenosis, ongoing hemolysis) vs. conjugated/cholestatic (biliary atresia, neonatal hepatitis, choledochal cyst, galactosemia, tyrosinemia, alpha-1 antitrypsin deficiency). Ask about cephalocaudal progression (Kramer's dermal zones) and rapidity of spread (suggests severe active hemolysis).
• Characterization of Stool & Urine (Unconjugated vs. Conjugated): Stool — normal yellow/mustard/golden-brown vs. chalky white, pale grey, or clay-colored/acholic (hallmark of biliary obstruction / extrahepatic biliary atresia or severe neonatal cholestasis). Urine — clear/water-like (normal; unconjugated bilirubin is albumin-bound and not excreted) vs. dark yellow, high-tea colored, or staining the diaper (conjugated hyperbilirubinemia).
• Feeding Behavior & Hydration Status: Feeding type (exclusive breastfeeding vs. formula vs. mixed), time to first feed, frequency, latching, duration of active suckling. Breastfed jaundice (lactation failure): Day 2–5; inadequate intake, dehydration, delayed meconium, increased enterohepatic circulation. Breast milk jaundice: Day 4–7, peak at 2 weeks, may persist 3–12 weeks; well-thriving baby, substances in breast milk inhibiting UGT1A1 or promoting enterohepatic clearance. Hydration: wet diapers (normal ≥ 6–8/day); weight loss > 10% suggests starvation/dehydration exaggerating jaundice.
• Neurological Symptoms (Acute Bilirubin Encephalopathy — ABE Screening): Phase 1 (Early ABE): lethargy, hypotonia, poor sucking, high-pitched whimpering cry (reversible with prompt treatment). Phase 2 (Intermediate ABE): hypertonia, retrocollis, opisthotonos, fever, irritability, stupor (variable reversibility). Phase 3 (Advanced ABE): pronounced opisthotonos/retrocollis, shrieking cry, inability to feed, apnea, seizures, coma (irreversible basal ganglia damage).

flowchart TD
    A["Acute Bilirubin Encephalopathy (ABE)"] --> B["Phase 1: Early<br/>(Reversible)"]
    B --> C["Hypotonia, lethargy,<br/>poor feed, weak cry"]
    C --> D["Phase 2: Intermediate<br/>(Variable)"]
    D --> E["Hypertonia, retrocollis,<br/>opisthotonos, stupor"]
    E --> F["Phase 3: Advanced<br/>(Irreversible)"]
    F --> G["Severe opisthotonos,<br/>seizures, apnea, coma"]

Negative History (3C 1D Framework)

This framework systematically rules out pathology across Causes (etiological risks), Complaints (active neonatal distress), Complications (metabolic/neurological decompensation), and Differentials (critical mimics).

Other Relevant History

• Demographic Profile: Baby of Mother's Name (include gender — G6PD deficiency is X-linked recessive). Gestational age at birth: completed weeks + days via LMP and first-trimester dating ultrasound (crucial for Bhutani / AAP / WHO hour-specific phototherapy and exchange transfusion curves). Chronological age: exact hours of life if ≤ 72 hours or completed days if > 72 hours (bilirubin nomograms are hour-specific). Date and exact time of birth. Birth order and gravidity (e.g., Second born/G2P1L1 — history of affected older siblings). Parents' consanguinity (raises suspicion for autosomal recessive disorders: Crigler-Najjar, galactosemia, Byler disease, RBC membrane defects). Parental blood groups: maternal and paternal ABO and Rh status (Rh incompatibility, ABO incompatibility, minor group antigens — Kell, Duffy, Kidd, anti-c, anti-E). Socioeconomic status (Modified Kuppuswamy / BG Prasad Scale). Informant and reliability. Present setting: NICU / SNCU / postnatal ward under phototherapy or evaluation for hyperbilirubinemia.
• Antenatal History: Maternal blood group and Rh status — Rh negative (Indirect Coombs Test titers; Anti-D at 28 weeks and within 72 hours post-delivery). Maternal blood group O (ABO isoimmunization risk). Maternal illnesses: GDM (polycythemia, delayed hepatic maturation), hypothyroidism, TORCH spectrum. Antenatal medications: sulfonamides, nitrofurantoin, antimalarials (G6PD risk), oxytocin (increases osmotic fragility of fetal RBCs). Antenatal ultrasound: fetal hydrops (severe Rh isoimmunization), abdominal cysts (choledochal cyst), echogenic bowel (meconium ileus/cystic fibrosis).
• Natal (Intrapartum) History: Gestation at delivery — preterm (< 37 weeks) neonates have immature UGT1A1, lower albumin, permeable blood-brain barrier → higher kernicterus risk at lower TSB. Mode of delivery: assisted delivery causing caput, cephalohematoma, or facial bruising. Cord clamping: immediate vs. delayed (> 60 seconds) — DCC increases iron stores but slightly elevates polycythemia and physiological jaundice risk. Intrapartum asphyxia: low Apgar, delayed cry, fetal distress — hypoxia/acidosis disrupt albumin-bilirubin binding.
• Family History: Three-generation pedigree — jaundice, anemia, early splenectomy, or cholecystectomy in relatives (hereditary spherocytosis, G6PD, thalassemia); neonatal death or kernicterus in siblings; phototherapy or exchange transfusion in older siblings; liver disease or metabolic diseases in siblings (Crigler-Najjar, Byler disease, galactosemia).

• Socioeconomic Status, KAP & Cultural Practices: Access to healthcare and timely bilirubin testing. Dangerous myths: direct sunlight without eye protection; turmeric/oil/kajal application; stopping breastfeeding believing milk is "poisonous." Awareness of jaundice progression to soles and ABE danger signs (lethargy, poor feeding).

History Summary

Summarize the history using a structured, academic format to present to the examiner without premature labeling. Template: "A exact hours / days old Male / Female neonate, Birth Order born to a Maternal Blood Group, e.g., O Rh +ve mother and Paternal Blood Group, e.g., B Rh +ve father by consanguineous / non-consanguineous marriage, born at Gestational Age weeks via NVD / LSCS with a birth weight of Weight in kg, presenting with yellowish discoloration of skin noticed since exact hours of life, starting from face and progressing up to Kramer zone / abdomen / soles. There is no history of pale stools or dark urine / history of acholic stools and urine staining, no history of lethargy, refusal to feed, abnormal arching, or seizures. There is no maternal-fetal blood group incompatibility / presence of ABO disparity, no sibling history of severe jaundice or exchange transfusion, and baby is currently rooming-in on demand breastfeeding / under phototherapy in NICU with adequate / inadequate weight trajectory and voiding pattern.".

General & Head-to-Toe Examination

• Environmental Prerequisites: Examine under natural daylight near a window (fluorescent or yellow room light obscures icterus; phototherapy blue lights must be off during visual skin assessment).
• Visual Dermal Icterus Assessment (Kramer's Rule): Blanch skin with light thumb pressure over bony prominences; release and observe underlying dermal color. Clinical pearl: Kramer's rule overestimates TSB in dark-skinned infants and underestimates after phototherapy (skin bleaches while serum levels remain elevated).

• Vitals & Hemodynamics:
  • Heart Rate: 120–160 bpm (tachycardia suggests severe anemia/hemolysis or sepsis).
  • Respiratory Rate: 40–60 breaths/min (tachypnea suggests cardiac failure from severe hemolytic anemia or pneumonia).
  • Axillary Temperature: 36.5–37.5°C (hypothermia/fever in sepsis).
  • Capillary Refill Time (CRT): < 3 seconds.
  • Hydration Signs: Anterior fontanelle level, skin turgor, oral mucosa dryness, weight loss percentage from birth weight.
• Extravascular Blood Collections (Etiological Evaluation): Cephalohematoma (subperiosteal, restricted by sutures, fluctuant with hard raised margin). Subgaleal hemorrhage (crosses sutures, massive, gravity-dependent shift → profound anemia and hyperbilirubinemia). Caput succedaneum (subcutaneous edema, present at birth, crosses sutures, resolves 48–72 hours). Ecchymoses and petechiae (traumatic delivery or TORCH/sepsis).
• Features of Hemolysis & Anemia: Pallor of conjunctiva, palmar creases, and tongue (pallor + jaundice = hemolytic anemia until proven otherwise). Plethora — deep ruddy blue-red appearance (polycythemia; hematocrit > 65%).
• Features Suggestive of Sepsis or TORCH: Hepatosplenomegaly (liver > 2 cm below costal margin; palpable spleen). Skin markers: purpuric lesions ("blueberry muffin" spots in CMV/Rubella), congenital cataracts, chorioretinitis, microcephaly.
• Features Suggestive of Congenital Hypothyroidism: Large open posterior fontanelle (> 0.5 cm), umbilical hernia, macroglossia, coarse facies, dry skin, hypotonia.
• Neurological Assessment for ABE (BIND Score): Bilirubin-Induced Neurological Dysfunction score — 3 domains, each 0–3 (total 0–9):

- _BIND 1–3:_ mild ABE (reversible). _BIND 4–6:_ moderate ABE (urgent exchange transfusion; potentially reversible). _BIND 7–9:_ severe ABE (likely irreversible).

Systemic Examination

1. Abdominal & Gastrointestinal System

• Inspection: Contour (normally full; distension in sepsis/peritonitis), umbilical stump (omphalitis, oozing blood, patent urachus/vitellointestinal duct).
• Palpation: Liver — measure span; edge soft/smooth (normal 1–2 cm), firm/hard (biliary atresia, cirrhosis), nodular (TORCH/storage disease). Spleen — tip palpable in 10–15% of healthy neonates; moderate-to-massive splenomegaly indicates active hemolysis or intrauterine infection.
• Stool Inspection (In-person Verification): Check actual diaper stool color against Infant Stool Color Card (ISCC) — crucial for early biliary atresia detection before 60 days for successful Kasai portoenterostomy.

2. Central Nervous System

• Tone: Passive tone (popliteal angle, scarf sign, arm recoil) and active tone (pull-to-sit, vertical/ventral suspension). Hypotonia — early ABE and sepsis. Extensor hypertonia/retrocollis — intermediate-to-advanced ABE.
• Primitive Reflexes: Moro — sluggish/incomplete in early ABE; asymmetric in brachial plexus injury or clavicle fracture; absent in severe ABE. Sucking and rooting — poor/absent in severe hyperbilirubinemia.

3. Cardiovascular & Respiratory Systems

• Precordial heave, hyperdynamic precordium, or functional ejection systolic murmur at left sternal border in severe anemia secondary to Rh isoimmunization.

Diagnostic Approach & Laboratory Investigations

flowchart TD
    A["Neonatal Jaundice Evaluation"] --> B["Measure Total & Direct Bilirubin"]
    B --> C{"Direct bilirubin<br/>< 1.5 mg/dL or < 20% of total?"}
    C -->|Yes| D["Unconjugated Hyperbilirubinemia"]
    C -->|No| E["Conjugated Hyperbilirubinemia<br/>Workup: USG, HIDA/MRCP, LFTs,<br/>thyroid, metabolic screen"]
    D --> F["Direct Coombs Test (DCT)"]
    F --> G{DCT result?}
    G -->|Positive| H["Isoimmunization<br/>Rh / ABO / minor antigens"]
    G -->|Negative| I["Check Hb / Hematocrit"]
    I --> J{Hct > 65%?}
    J -->|Yes| K["Polycythemia"]
    J -->|No| L["Check Reticulocyte Count"]
    L --> M{Elevated retics?}
    M -->|Yes| N["Peripheral smear<br/>Spherocytes / G6PD / Heinz bodies"]
    M -->|No| O["Non-hemolytic causes<br/>Breastfed / breast milk jaundice,<br/>cephalohematoma, sepsis, hypothyroidism"]

Management Protocols (IAP / AAP Guidelines)

Phototherapy

• Mechanism of Action: Converts toxic 4Z,15Z-bilirubin into water-soluble isomers excreted without conjugation:
  • Structural isomerization (primary, irreversible): lumirubin — rapidly excreted in bile and urine.
  • Photo-isomerization (reversible): 4Z,15Z → 4Z,15E isomer.
  • Photo-oxidation (minor): breakdown into small polar molecules.
• Wavelength & Light Source: Blue-green spectrum (460–490 nm); high-intensity LED units 30–45 cm above baby.
• Irradiance: Standard phototherapy 8–10 µW/cm²/nm; intensive phototherapy ≥ 30 µW/cm²/nm (maximum body surface area — panels above and bilaterally/below).

flowchart TD
    A["4Z,15Z Bilirubin (Toxic)"] --> B["Phototherapy Light<br/>460–490 nm"]
    B --> C["Structural Isomerization"]
    B --> D["Photo-isomerization"]
    B --> E["Photo-oxidation"]
    C --> F["Lumirubin<br/>(Irreversible, fast)"]
    D --> G["4Z,15E Bilirubin<br/>(Reversible)"]
    E --> H["Polar monopyrroles<br/>(Minor)"]
    F --> I["Excreted in urine & bile<br/>(No conjugation needed)"]
    G --> I
    H --> I

• Care of Infant Under Phototherapy Checklist:
  • Eye protection with dark patches (prevents retinal damage).
  • Genital protection with minimal diaper cover (maximizes surface area exposure).
  • Maintain thermal environment (36.5–37.5°C).
  • Continue breastfeeding every 2–2.5 hours (increase fluid volume by 10–15% for insensible water loss).
  • Monitor TSB every 6–12 hours in active hemolysis.
  • Do not apply oil or lotions to skin (prevents burns/tanning).

Exchange Transfusion

• Indications: Failure of intensive phototherapy to stop TSB rise; TSB reaching hour-specific exchange thresholds; signs of ABE (retrocollis, opisthotonos).
• Volume: Double Volume Exchange Transfusion (DVET) = 2 × blood volume × weight (kg) = 2 × 80–90 mL/kg = 160–180 mL/kg.
• Blood Component Selection:
  • Rh isoimmunization: O Rh-negative PRBCs cross-matched with maternal serum, suspended in AB Rh-compatible FFP (hematocrit 45–50%).
  • ABO isoimmunization: O group PRBCs (Rh-compatible) in AB group plasma.
  • Blood age: Fresh reconstituted blood (< 5 days old, irradiated, leukocyte-depleted).

Pharmacotherapy

• IVIG: 0.5–1.0 g/kg IV over 2–4 hours in isoimmune hemolytic jaundice (Rh or ABO) when TSB rising despite intensive phototherapy (blocks Fc receptors on macrophages).
• Phenobarbital: Increases UGT1A1 synthesis; used in Crigler-Najjar Type II and severe hyperbilirubinemia in low-resource settings.
• Ursodeoxycholic Acid (UDCA): 10–20 mg/kg/day in conjugated hyperbilirubinemia / cholestasis to enhance bile flow.

Pre-Discharge Risk Stratification & Follow-Up

Before discharging any neonate with resolved or mild jaundice, verify:

• Bhutani Nomogram Plotting: Plot pre-discharge TSB/TcB on hour-specific Bhutani curve — Low Risk (< 40th percentile): follow-up in 48–72 hours if needed; High-Intermediate (75th–95th percentile): re-evaluate TSB within 24 hours; High Risk (> 95th percentile): initiate/continue phototherapy; do not discharge.
• Lactation & Hydration Adequacy: Demonstrated good latching and weight loss < 8–10%.
• Parental Education: Recognize jaundice progression to thighs/soles and ABE danger signs (lethargy, poor feeding).

Final Summary & Diagnosis

Clinical Summary Template: "Baby of Mother's Name, a exact hours / days old Male / Female neonate, Birth Order born to a Maternal Blood Group mother and Paternal Blood Group father by consanguineous / non-consanguineous marriage, born at Gestational Age weeks by NVD / LSCS with a birth weight of Weight in kg. Presented with yellowish discoloration of skin noticed since exact hours of life, rapidly progressing to Kramer zone / soles. Physical examination reveals a well / sick infant with presence / absence of pallor, cephalhematoma, or hepatosplenomegaly. Neurological evaluation demonstrates normal tone and reflexes / BIND score of X with no signs of ABE. Laboratory investigations show TSB of Value in mg/dL with direct fraction of Value mg/dL, positive / negative Direct Coombs Test, and presence / absence of reticulocytosis on smear. The baby was managed with intensive phototherapy / IVIG / double volume exchange transfusion and is currently stable.".

Final Diagnosis Format: State the diagnosis mapping to maturity, growth category, postnatal age, etiology, severity, neurological status, and current treatment: "A Postnatal Age in hours or days old, Term / Preterm (Gestational Age in weeks), Male / Female neonate, AGA / SGA / LGA, with a birth weight of Weight in kg, born via NVD / LSCS, presenting with severe unconjugated hyperbilirubinemia secondary to Rh Isoimmunization / ABO Incompatibility / G6PD Deficiency / Breastfed Jaundice / Physiological Jaundice, with no evidence of Acute Bilirubin Encephalopathy (ABE) / features of Stage-1 ABE, currently stable under intensive phototherapy / post-double volume exchange transfusion."

Example (Isoimmune Case): "A 48-hour-old full-term (38 weeks + 4 days) male neonate, Appropriate for Gestational Age (AGA), with a birth weight of 3.1 kg, born via normal vaginal delivery to an O Rh-negative mother, presenting with severe pathological unconjugated hyperbilirubinemia secondary to Rh Isoimmunization (DCT positive), with no clinical evidence of acute bilirubin encephalopathy, currently receiving intensive LED phototherapy and IVIG.".

Related

• Topic Hub
• Viva Questions
• Model Case Sheet